AI Biotech Enveda Doubles in Value to $2 Billion — WSJ

By Xavier MartinezEnveda, a privately held AI biotechnology startup, has doubled its valuation to about $2 billion as momentum builds behind tech-driven approaches to discovering new medicines.The financing will help the Boulder, Colo.-based company fund later-stage human trials. Healthcare investo…